🔗 Permalink

Inventor profile of:

Samir P. Tabash

City:

Whitby

Country:

Canada

Published Applications:

Last publication date:

2026-02-05

Top Assignees for applications by Samir P. Tabash

The entities that hold a legal rights for patent applications filed by inventor Tabash Samir P.:

OPKO IRELAND GLOBAL HOLDINGS, LTD. 10 Grand Cayman, Cayman Islands
Eirgen Pharma Ltd. 7 Waterford, Ireland
OPKO RENAL, LLC 5 Miami, FL United States
CYTOCHROMA INC. 3 Markham, Canada
PROVENTIV THERAPEUTICS, LLC 3 Bannockburn, IL United States
OPKO IRELAND GLOBAL HOLDINGS, LIMITED 1 Grand Cayman, Cayman Islands
CYTOCHROMA INC. 1 Markham, Ontario, Canada
PROVENTIV THERAPEUTICS, LLC 1 Mount Horeb, WI United States
Opko IP Holdings II, Inc. 1 Grand Cayman, Cayman Islands
CYTOCHROMA 1 Bannockburn, IL United States
Opko IP Holdings II, Inc. 1 Miami, FL United States

Recent patent applications by Tabash Samir P.

Samir P. Tabash from Whitby, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-05

US20260034148A1

Human necessities

STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME

#2 | 2023-11-02

US20230346804A1

Human necessities

METHODS AND COMPOSITIONS FOR REDUCING PARATHYROID LEVELS

#3 | 2022-04-28

US20220125806A1

Human necessities

STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME

#4 | 2021-08-26

US20210260079A1

Human necessities

Adjunctive therapy with 25-hydroxyvitamin D and articles therefor

#5 | 2020-08-13

US20200253988A1

Human necessities

ADJUNCTIVE THERAPY WITH 25-HYDROXYVITAMIN D

#6 | 2020-04-02

US20200101089A1

Human necessities

Adjunctive therapy with 25-hydroxyvitamin D and articles therefor

#7 | 2019-12-12

US20190374555A1

Human necessities

Stabilized modified release Vitamin D formulation and method of administering same

#8 | 2019-05-16

US20190142847A1

Human necessities

Adjunctive therapy with 25-hydroxyvitamin D and articles therefor

#9 | 2018-09-27

US20180271885A1

Human necessities

Stabilized modified release vitamin D formulation and method of administering same

#10 | 2018-09-27

US20180271884A1

Human necessities

Stabilized modified release vitamin D formulation and method of administering same

#11 | 2018-05-03

US20180117068A1

Human necessities

Stabilized modified release vitamin D formulation and method of administering same

#12 | 2018-02-01

US20180028453A1

Human necessities

Methods for controlled release oral dosage of a vitamin D compound

#13 | 2018-01-25

US20180021354A1

Human necessities

Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor

#14 | 2017-05-04

US20170119677A1

Human necessities

Method for treating secondary hyperparathyroidism in CKD

#15 | 2016-12-01

US20160346299A1

Human necessities

Method for controlled release oral dosage of a vitamin D compound

#16 | 2016-02-11

US20160038514A1

Human necessities

Adjunctive therapy with 25-hydroxyvitamin D and articles therefor

#17 | 2015-08-06

US20150216881A1

Human necessities

Method for treating secondary hyperparathyroidism in CKD

#18 | 2014-12-04

US20140357603A1

Human necessities

Methods for controlled release oral dosage of a vitamin D compound

#19 | 2014-11-27

US20140349979A1

Human necessities

Stabilized modified release vitamin D formulation and method of administering same

#20 | 2013-05-30

US20130137663A1

Human necessities

Methods and compositions for reducing parathyroid levels

#21 | 2013-05-23

US20130131022A1

Human necessities

Methods for controlled release oral dosage of a vitamin D compound

#22 | 2012-01-19

US20120015916A1

Human necessities

Method for treating secondary hyperparathyroidism in CKD

#23 | 2010-05-13

US20100120728A1

Human necessities

Method of treating vitamin D insufficiency and deficiency

#24 | 2009-07-09

US20090176748A1

Human necessities

Methods and compositions for controlled release oral dosage of a vitamin D compound

InventorID:

263610 ⎘